UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Dll4-Notch signaling as a therapeutic target in tumor angiogenesis

Vascular cell, 2011-09, Vol.3 (1), p.20-20

2011

Volltextzugriff (PDF)

Elesclomol induces cancer cell apoptosis through oxidative stress

Molecular cancer therapeutics, 2008-08, Vol.7 (8), p.2319-2327

2008

Volltextzugriff (PDF)

In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy

BMC bioinformatics, 2016-07, Vol.17 (1), p.286-286, Article 286

2016

Volltextzugriff (PDF)

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies

Clinical and translational science, 2022-04, Vol.15 (4), p.954-966

2022

Volltextzugriff (PDF)

Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

Molecular cancer therapeutics, 2017-04, Vol.16 (4), p.681-693

2017

Volltextzugriff (PDF)

A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys

Scientific reports, 2015-12, Vol.5 (1), p.17943-17943, Article 17943

2015

Volltextzugriff (PDF)

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

Science translational medicine, 2020-01, Vol.12 (525)

2020

Volltextzugriff (PDF)

Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target

Journal of Virology, 2005-07, Vol.79 (14), p.9320-9324

2005

Volltextzugriff (PDF)

Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer

Cancer research (Chicago, Ill.), 2015-10, Vol.75 (19), p.4086-4096

2015

Volltextzugriff (PDF)

Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids

Bioorganic & medicinal chemistry, 2020-12, Vol.28 (23), p.115785-115785, Article 115785

2020

Volltextzugriff (PDF)

A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation

Cancer immunology research, 2020-05, Vol.8 (5), p.596-608

2020

Volltextzugriff (PDF)

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Bioorganic & medicinal chemistry, 2018-05, Vol.26 (9), p.2271-2279

2018

Volltextzugriff (PDF)

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

Blood advances, 2021-03, Vol.5 (5), p.1291-1304

2021

Volltextzugriff (PDF)

Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers

Molecular cancer therapeutics, 2017-07, Vol.16 (7), p.1299-1311

2017

Volltextzugriff (PDF)

Preclinical PET imaging with the novel human antibody 89 Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e002025

2021

Volltextzugriff (PDF)

Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells

Journal of Virology, 1999-11, Vol.73 (11), p.9348-9361

1999

Volltextzugriff (PDF)

Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054

Cancer immunology research, 2022-10, Vol.10 (10), p.1190-1209

2022

Volltextzugriff (PDF)

Reactivation of Kaposi's Sarcoma-Associated Herpesvirus Infection from Latency by Expression of the ORF 50 Transactivator, a Homolog of the EBV R Protein

Virology (New York, N.Y.), 1998-12, Vol.252 (2), p.304-312

1998

Volltextzugriff (PDF)

ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts

Molecular pharmaceutics, 2018-06, Vol.15 (6), p.2133-2141

2018

Volltextzugriff (PDF)

DNA Binding by Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Is Necessary for Transcriptional Activation of Two Viral Delayed Early Promoters

Journal of Virology, 2001-08, Vol.75 (15), p.6786-6799

2001

Volltextzugriff (PDF)

Ongoing Dll4‐Notch signaling is required for T‐cell homeostasis in the adult thymus

European journal of immunology, 2011-08, Vol.41 (8), p.2207-2216

2011

Volltextzugriff (PDF)

Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1)

2021

Volltextzugriff (PDF)

Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis

Journal of Virology, 1999-07, Vol.73 (7), p.6006-6014

1999

Volltextzugriff (PDF)

Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 57 Encodes a Posttranscriptional Regulator with Multiple Distinct Activities

Journal of Virology, 2000-04, Vol.74 (8), p.3586-3597

2000

Volltextzugriff (PDF)

Exploring mechanisms of tumor resistance to CAR T cell therapy in immunocompetent mouse models

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.170-170.24

2020

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dll4-Notch signaling as a therapeutic target in tumor angiogenesis

Elesclomol induces cancer cell apoptosis through oxidative stress

In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies

Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys

A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target

Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer

Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids

A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers

Preclinical PET imaging with the novel human antibody 89 Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues

Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells

Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054

Reactivation of Kaposi's Sarcoma-Associated Herpesvirus Infection from Latency by Expression of the ORF 50 Transactivator, a Homolog of the EBV R Protein

ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts

DNA Binding by Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Is Necessary for Transcriptional Activation of Two Viral Delayed Early Promoters

Ongoing Dll4‐Notch signaling is required for T‐cell homeostasis in the adult thymus

Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues

Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi’s Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis

Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 57 Encodes a Posttranscriptional Regulator with Multiple Distinct Activities

Exploring mechanisms of tumor resistance to CAR T cell therapy in immunocompetent mouse models

Suchergebnisse filtern